Skip to content

Ditto Biosciences

YC W26 · Active · Evolutionary intelligence for autoimmune disease

Competitors

Adjacent

Also from W26 in AI

All of W26

Founders

  • Dennis SunFounder/CEO
  • Adair BorgesFounder
  • Emily WeissFounder

About Ditto Biosciences

Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology. Viruses, ticks, and worms have experimented over millions of years to create proteins that control the human immune system. We use AI to identify these proteins and engineer them into next-generation autoimmune therapies. Our team is three PhD scientists from UCSF, UCSD, and UC Berkeley who have worked together for 3+ years in biotech. We have deep expertise in parasite biology, computational biology, and software for AI-based protein structure prediction

YC batch
W26 · Winter 2026
Status, per YC
Active
Category
AI
Team size
3
Location
San Francisco, CA, USA
Founded
2025
Checked
1h ago

Ditto Biosciences in W26: 199 companies, 80% AI

LinkedIn

Ditto Biosciences: questions

Which YC batch was Ditto Biosciences in?

Ditto Biosciences was in Y Combinator's Winter 2026 batch (W26).

Is Ditto Biosciences still active?

Y Combinator lists Ditto Biosciences as active.

Who founded Ditto Biosciences?

Ditto Biosciences's founders, as listed on its YC page: Dennis Sun (Founder/CEO), Adair Borges (Founder), Emily Weiss (Founder).

Where is Ditto Biosciences based?

Ditto Biosciences lists San Francisco, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.